Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3

被引：0
|
作者：
Hidetaka Akita
Hiroshi Suzuki
Tomoko Hirohashi
Hajime Takikawa
Yuichi Sugiyama
机构：
[1] The University of Tokyo,Graduate School of Pharmaceutical Sciences
[2] Teikyo University School of Medicine,Department of Medicine
来源：
Pharmaceutical Research | 2002年 / 19卷
关键词：
ABC transporter; bile acids; MRP3; organic anion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. Multidrug resistance-associated protein 3 (MRP3) was initially cloned as a hepatic transporter induced under cholestatic/hyperbilirubinemic conditions. In the present study, transport property of human MRP3 (hMRP3) was compared with that of rat MRP3 (rMRP3).
引用
收藏
页码：34 / 41
页数：7
相关论文
共 50 条
  • [31] Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients
    Sedlakova, I
    Laco, J.
    Tosner, J.
    Spacek, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2015, 80 (06): : 405 - 413
  • [32] Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells
    Wang, Xuan-Bin
    Wang, Shan-Shan
    Zhang, Qiu-Fang
    Liu, Ming
    Li, Hong-Liang
    Liu, Ying
    Wang, Jia-Ning
    Zheng, Fei
    Guo, Ling-Yun
    Xiang, Ji-Zhou
    ONCOLOGY REPORTS, 2010, 23 (01) : 211 - 215
  • [33] Altered disposition of acetaminophen in MRP3 knockout mice.
    Manautou, J
    de Waart, R
    Zelcer, N
    Kunne, C
    van de Wetering, KV
    Borst, P
    Elferink, RO
    HEPATOLOGY, 2004, 40 (04) : 276A - 276A
  • [34] Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in human glioma
    Calatozzolo, C
    Gelati, M
    Ciusani, E
    Sciacca, FL
    Pollo, B
    Cajola, L
    Marras, C
    Silvani, A
    Vitellaro-Zuccarello, L
    Croci, D
    Boiardi, A
    Salmaggi, A
    JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (02) : 113 - 121
  • [35] Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma
    C. Calatozzolo
    M. Gelati
    E. Ciusani
    F. L. Sciacca
    B. Pollo
    L. Cajola
    C. Marras
    A. Silvani
    L. Vitellaro-Zuccarello
    D. Croci
    A. Boiardi
    A. Salmaggi
    Journal of Neuro-Oncology, 2005, 74 : 113 - 121
  • [36] MRP3 As a Novel Resistance Factor for Sorafenib in Hepatocellular Carcinoma
    Tomonari, Tetsu
    Takeishi, Shunsaku
    Taniguchi, Tatsuya
    Tanaka, Takahiro
    Tanaka, Hironori
    Kimura, Tetsuo
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Takayama, Tetsuji
    GASTROENTEROLOGY, 2016, 150 (04) : S514 - S514
  • [37] THE ROLE OF MRP3 IN THE GENERATION OF CLOPIDOGREL ACTIVE METABOLITE.
    Tai, T.
    Mi, Q. Y.
    Pan, Y. Q.
    Yin, Q.
    Xie, H. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S36 - S37
  • [38] MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
    Tomonari, Tetsu
    Takeishi, Shunsaku
    Taniguchi, Tatsuya
    Tanaka, Takahiro
    Tanaka, Hironori
    Fujimoto, Shota
    Kimura, Tetsuo
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Takayama, Tetsuji
    ONCOTARGET, 2016, 7 (06) : 7207 - 7215
  • [39] Altered disposition of acetaminophen in Mrp3 knockout mice.
    Manautou, J
    de Waart, R
    Zelcer, N
    Kunne, C
    Borst, P
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A51 - A51
  • [40] MRP3, an organic anion transporter able to transport anti-cancer drugs
    Kool, M
    van der Linden, M
    de Haas, M
    Scheffer, GL
    de Vree, JML
    Smith, AJ
    Jansen, G
    Peters, GJ
    Ponne, N
    Scheper, RJ
    Elferink, RPJO
    Baas, F
    Borst, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6914 - 6919
12345